SOX2 and central nervous system cancer: However, inhibition of mTORC1 has also been described to attenuate SOX2 and further downstream SOX9 expression in glioma [102], and both PI3K inhibitors and rapamycin reported to suppress SOX2-driven tumorigenicity from esophageal squamous cells in a murine xenografts [103].